Results 191 to 200 of about 18,058,309 (312)
The novel circRNA circFAM65A suppresses HCC progression. Mechanistically, circFAM65A drives CANX phase separation, which recruits FAM134B into condensates and blocks its interaction with LC3, thereby inhibiting ER‐phagy and HCC progression. Importantly, targeted circFAM65A delivery represents a potential therapeutic strategy for HCC.
Wenxiu Ru +15 more
wiley +1 more source
Artificial intelligence for translational personalized neoantigen cancer vaccine development. [PDF]
Wei CY +12 more
europepmc +1 more source
An active biomaterial‐based bi‐adjuvant nanovaccine restores the immunocompetence of aged dendritic cells to overcome senescent cell tolerance. Accompanied by the downregulation of mitotic kinases Aurka/b and attenuation of senescence‐associated PI3K/AKT phosphorylation, the nanovaccine enhances antigen‐presenting capacity and promotes potent cytotoxic
Qingxu Song +5 more
wiley +1 more source
Encephalitic Alphaviruses: Epidemiology, Pathogenesis and Vaccine Development. [PDF]
Kisra N +6 more
europepmc +1 more source
X‐shaped DNA promotes multivalent cGAS assembly and enhances cGAS‐STING signaling. When conjugated with antigenic peptides, the resulting X‐DNA‐based peptide vaccine promotes dendritic cell activation, antigen presentation, and antitumor T‐cell responses.
Jiabei Li +7 more
wiley +1 more source
Deep learning-based structure modeling of the Treponema pallidum proteome: Insights into pathogenesis and syphilis vaccine development. [PDF]
Houston S +5 more
europepmc +1 more source
TRIM28 binds to DDX3 protein to catalyze the SUMOylation of DDX3 (S‐DDX3), thus the S‐DDX3 involves in aberrant alternative splicing of KLF4 mRNA, and the splicing variant KLF4α‐mediated cell cycle and signal transduction, weakens tumor suppressor function of DDX3 protein, which promotes progression of HBV‐HCC.
Yanfang Yang +8 more
wiley +1 more source
Malaria serology for surveillance, insights into immunity, and vaccine development. [PDF]
Lim PS +3 more
europepmc +1 more source
Defeating Multidrug‐Resistant ESKAPEE Pathogens With Polymer Nanomaterials
Antimicrobial resistance, particularly among ESKAPEE pathogens, represents a major global health threat and drives the need for innovative treatments. Polymer‐based strategies offer promising alternatives to conventional antibiotics by overcoming resistance mechanisms.
Thu Ba Tô +4 more
wiley +1 more source
Antiviral Candidates and Vaccine Development for the Neglected Oropouche Virus. [PDF]
Soares VC, Dias SSG.
europepmc +1 more source

